# pathway_0043: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0043.txt)

**Task:** `pathway`  
**Author key, unchanged:** **A** — Pigment biosynthesis. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MDNISNHAFNYPVLVLNKGLLPEHDDIALARYLFSALALAVSRITQNEEMIVGFHLHPQEITRWKDDECIRQYILPLNIRFNSATPIAGFIREIMTWMTPDAIHQKNAMGASVLTLGPQHALHDIFDLEISWQPPVESEPVQALTCHVASREDALVLTLRFNPARFSATQMQKLPEVWRQITASAAKNGAETLRDIGLIDDAERQRVLHAFNQTEQAWDGETTVAARLKNRAQRHPEQTAVVFRDETLSYRQLYQQAGALAHYLNALETERERCVGLFVEPSLTLMTGVWGILLSGNAYLPLSPEYPEDRLAYMLENSQTRIIVTQPHLRERLLALAPPGIQVVTSDDVDAFMRQHAHSLPDAPQNDIAPHHLAYVIYTSGSTGKPKGVMIEHHSVLNQMNWLAQTVGLNQETVILQKTPMSFDAAQWEILSPACGCRVVMGEPGVYRNPEQLVDMLAEYRVTTLQCVPTLLQALLDTERLTHCPALRQIFSGGEALQKHLAQACLETLPDCELINLYGPTECTINNSAFRVDPVSVRQGPDTLSIGAPVANTRYYILDNCLTPVAVGQIGELYIGGDGVARGYLNRDDLTAERFIVDPFAPAGSGRRLYQTGDIASWNPDGTVQYAGRADNQVKLRGYRVELDEIRSAIETHEWVKAAAVIVRNDPFTGYQNLISFIELNAREAALMDQGNHGSHHQSKADKAQVMLQLANKGCREFPAASQPYTLDLPGKQPDEKQRLTAFSRKTYRFYDGGAVSREDILSLLHEPLLTAISRQPDALTLDELGHWLRYLGQFTSAERLLPKYTYASPGALYATQVFLELNGVAGLTAGHYYYQPVHHQLVRVSEQAAVTPGSLRLHFVGKKSAIEPIYKNNIREVLQMEMGHIIGMLDIILPDYGLGVALCDAAALDPTPLAIDLDDDYLGACDVLSGPRLPTDDDLDIYVQTAGANIADLPVGTYRYVRGDLQHIADDVIDKKHVIAINQAVYERSSFGISVASRTEGWAGYVHVGRKLQRLQMNPLNIGLMSSGYSSETGNDLPAARRFWQILGHRTGPYYFFIGGRISDEQKYSEGMREDAVHMKGPAEMIRDDLAAFMPDYMMPNKVLILDEMPLTANGKIDMKALANINVELKHKTIVAPRNPLEHQVMAIWQAKLKREEMSVDDNFFESGGNSLIAVSLINELNATLNASLPLQVLFQAPTVEKLAAWLSRARREPVSRLVQLQPKGRQAPIYCWPGLGGYCMNLRLLARQLGAERPFFGIQAHGINPDETPYATIGEMAARDIELIRQHQPHGPYTLWGYSFGARVAFETAWQLELAGEVVENLYLLAPGSPKLRDERVAAMNRKADFDNPGYLTILFSVFIGSITDPELERCLETVRDEESFVAFITGLNPALDDGLVRRITRIVAQTFEFTYTFSELQQRQLNAPVTIIKAQGDDYSFIENHGGFSAQPPTVLELMADHYSMLKAPGIDELTSVIQYQQSPPSLVG

[Multiple Choices]
A. Pigment biosynthesis. .
B. Alkaloid biosynthesis. .
C. NAD(+) from nicotinamide D-ribonucleotide: step 1/1. .
D. L-threonine from L-aspartate: step 2/5. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact supplied sequence matches the annotated indigoidine synthase. Its pathway annotation is “Pigment biosynthesis,” with experimental evidence cited to PubMed 11790734, supporting choice A for this sequence.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The long sequence is consistent with a large biosynthetic enzyme, which may help distinguish it from the small NAD-related or threonine-pathway enzymes in choices C and D. That general clue does not meaningfully distinguish pigment biosynthesis from alkaloid biosynthesis.


**Missing item-specific fact**

> The enzyme’s specific identity as indigoidine synthase and its product/pathway association are needed to select pigment biosynthesis over alkaloid biosynthesis.


**Reason**

> The sequence may support broad functional inference, but identifying this specific pathway requires item-specific knowledge not supplied in the question.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The matched sequence’s experimentally supported pathway annotation selects A; the other options are not equally supported.


### Important caveats

- The accession and annotation evidence are reviewer-only and were not provided to the evaluated model.
- The source sequence matches the benchmark sequence; the historical and current records identify the protein as indigoidine synthase.
- The author’s exact source snapshot is unknown, but the reviewed historical record also supports the pathway annotation.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The long sequence is consistent with a large biosynthetic enzyme, which may help distinguish it from the small NAD-related or threonine-pathway enzymes in choices C and D. That general clue does not meaningfully distinguish pigment biosynthesis from alkaloid biosynthesis.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The enzyme’s specific identity as indigoidine synthase and its product/pathway association are needed to select pigment biosynthesis over alkaloid biosynthesis.",
    "reason": "The sequence may support broad functional inference, but identifying this specific pathway requires item-specific knowledge not supplied in the question."
  },
  "case_id": "pathway_0043",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact supplied sequence matches the annotated indigoidine synthase. Its pathway annotation is “Pigment biosynthesis,” with experimental evidence cited to PubMed 11790734, supporting choice A for this sequence."
  },
  "important_caveats": [
    "The accession and annotation evidence are reviewer-only and were not provided to the evaluated model.",
    "The source sequence matches the benchmark sequence; the historical and current records identify the protein as indigoidine synthase.",
    "The author’s exact source snapshot is unknown, but the reviewed historical record also supports the pathway annotation."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched sequence’s experimentally supported pathway annotation selects A; the other options are not equally supported."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0043",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact supplied sequence matches the annotated indigoidine synthase. Its pathway annotation is “Pigment biosynthesis,” with experimental evidence cited to PubMed 11790734, supporting choice A for this sequence.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The long sequence is consistent with a large biosynthetic enzyme, which may help distinguish it from the small NAD-related or threonine-pathway enzymes in choices C and D. That general clue does not meaningfully distinguish pigment biosynthesis from alkaloid biosynthesis.",
    "missing_item_specific_fact": "The enzyme’s specific identity as indigoidine synthase and its product/pathway association are needed to select pigment biosynthesis over alkaloid biosynthesis.",
    "reason": "The sequence may support broad functional inference, but identifying this specific pathway requires item-specific knowledge not supplied in the question."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched sequence’s experimentally supported pathway annotation selects A; the other options are not equally supported."
  },
  "important_caveats": [
    "The accession and annotation evidence are reviewer-only and were not provided to the evaluated model.",
    "The source sequence matches the benchmark sequence; the historical and current records identify the protein as indigoidine synthase.",
    "The author’s exact source snapshot is unknown, but the reviewed historical record also supports the pathway annotation."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry Q9L391 (Indigoidine synthase, EC 4.3.3.9, IndC from Dickeya dadantii 3937) is annotated with PATHWAY: Pigment biosynthesis, supported by experimental evidence code ECO:0000269 (inferred from direct assay) from Reverchon et al. 2002 (PubMed:11790734), which characterized indigoidine biosynthetic genes and demonstrated the blue pigment's role in pathogenicity. The sequence matches exactly (SHA-256 confirmed). The annotation is experimentally grounded.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains hallmark non-ribosomal peptide synthetase (NRPS) domain motifs: a condensation-domain signature 'TSGSTGKPKG' (~position 530), adenylation-domain motifs ('YGPTEC', 'GAPVAN'), and a C-terminal thioesterase domain. NRPS enzymes synthesize peptide-type secondary metabolites (pigments such as indigoidine, violacein, prodigiosin; antibiotics; siderophores). Option C (NAD+ biosynthesis, a single-step transferase) and Option D (L-threonine biosynthesis step 2, homoserine dehydrogenase, ~450 aa) are eliminated because a 1488-aa multi-domain NRPS is categorically incompatible with those small single-domain enzymes. Option B (alkaloid biosynthesis) is disfavored because alkaloids are synthesized by entirely different enzymatic machinery (terpene synthases, P450 monooxygenases, methyltransferases), not NRPS assembly lines. Among the remaining choices, NRPS products that are colored compounds (e.g., indigoidine, a dipeptide of L-glutamine) fall squarely under pigment biosynthesis. Thus general NRPS biology plus elimination of incompatible options supports A over B, C, and D.


**Missing item-specific fact**

> Precise identification of this NRPS as indigoidine synthase (and thus the specific pigment) requires recognizing the exact sequence or knowing the product of IndC; however, the question can be answered by class-level reasoning without that specific fact.


**Reason**

> The NRPS domain architecture is extractable from sequence motifs, and general knowledge that NRPS products are peptide-type metabolites (not alkaloids, not single-step transferases, not amino-acid biosynthetic enzymes) meaningfully distinguishes A from B, C, and D. The argument does not require memorizing Q9L391's database entry.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> C and D are eliminated by enzyme class and size mismatch. B is disfavored because alkaloid biosynthesis does not employ NRPS assembly lines. A is the only option consistent with a large multi-domain NRPS producing a secondary metabolite among the listed categories. No other option is defensible.


### Important caveats

- The pathway annotation is experimentally supported (ECO:0000269) but the specific pigment identity (indigoidine) is not derivable from sequence motifs alone; the reasoning argument operates at the NRPS-class level.
- The UniProt entry was first publicly released 2025-02-05 (sequence version 2); the author's source snapshot is unknown. The 2002 primary paper predates the Swiss-Prot entry, so the underlying experimental data was available before the benchmark was constructed.
- NRPS enzymes also produce antibiotics and siderophores; the question's option set conveniently lacks those alternatives, making 'pigment biosynthesis' the only NRPS-compatible choice. A more challenging distractor set (e.g., 'antibiotic biosynthesis') could have made the question genuinely ambiguous without product-specific knowledge.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains hallmark non-ribosomal peptide synthetase (NRPS) domain motifs: a condensation-domain signature 'TSGSTGKPKG' (~position 530), adenylation-domain motifs ('YGPTEC', 'GAPVAN'), and a C-terminal thioesterase domain. NRPS enzymes synthesize peptide-type secondary metabolites (pigments such as indigoidine, violacein, prodigiosin; antibiotics; siderophores). Option C (NAD+ biosynthesis, a single-step transferase) and Option D (L-threonine biosynthesis step 2, homoserine dehydrogenase, ~450 aa) are eliminated because a 1488-aa multi-domain NRPS is categorically incompatible with those small single-domain enzymes. Option B (alkaloid biosynthesis) is disfavored because alkaloids are synthesized by entirely different enzymatic machinery (terpene synthases, P450 monooxygenases, methyltransferases), not NRPS assembly lines. Among the remaining choices, NRPS products that are colored compounds (e.g., indigoidine, a dipeptide of L-glutamine) fall squarely under pigment biosynthesis. Thus general NRPS biology plus elimination of incompatible options supports A over B, C, and D.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "Precise identification of this NRPS as indigoidine synthase (and thus the specific pigment) requires recognizing the exact sequence or knowing the product of IndC; however, the question can be answered by class-level reasoning without that specific fact.",
    "reason": "The NRPS domain architecture is extractable from sequence motifs, and general knowledge that NRPS products are peptide-type metabolites (not alkaloids, not single-step transferases, not amino-acid biosynthetic enzymes) meaningfully distinguishes A from B, C, and D. The argument does not require memorizing Q9L391's database entry."
  },
  "case_id": "pathway_0043",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt entry Q9L391 (Indigoidine synthase, EC 4.3.3.9, IndC from Dickeya dadantii 3937) is annotated with PATHWAY: Pigment biosynthesis, supported by experimental evidence code ECO:0000269 (inferred from direct assay) from Reverchon et al. 2002 (PubMed:11790734), which characterized indigoidine biosynthetic genes and demonstrated the blue pigment's role in pathogenicity. The sequence matches exactly (SHA-256 confirmed). The annotation is experimentally grounded."
  },
  "important_caveats": [
    "The pathway annotation is experimentally supported (ECO:0000269) but the specific pigment identity (indigoidine) is not derivable from sequence motifs alone; the reasoning argument operates at the NRPS-class level.",
    "The UniProt entry was first publicly released 2025-02-05 (sequence version 2); the author's source snapshot is unknown. The 2002 primary paper predates the Swiss-Prot entry, so the underlying experimental data was available before the benchmark was constructed.",
    "NRPS enzymes also produce antibiotics and siderophores; the question's option set conveniently lacks those alternatives, making 'pigment biosynthesis' the only NRPS-compatible choice. A more challenging distractor set (e.g., 'antibiotic biosynthesis') could have made the question genuinely ambiguous without product-specific knowledge."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "C and D are eliminated by enzyme class and size mismatch. B is disfavored because alkaloid biosynthesis does not employ NRPS assembly lines. A is the only option consistent with a large multi-domain NRPS producing a secondary metabolite among the listed categories. No other option is defensible."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0043",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry Q9L391 (Indigoidine synthase, EC 4.3.3.9, IndC from Dickeya dadantii 3937) is annotated with PATHWAY: Pigment biosynthesis, supported by experimental evidence code ECO:0000269 (inferred from direct assay) from Reverchon et al. 2002 (PubMed:11790734), which characterized indigoidine biosynthetic genes and demonstrated the blue pigment's role in pathogenicity. The sequence matches exactly (SHA-256 confirmed). The annotation is experimentally grounded.",
    "evidence_ids": ["C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains hallmark non-ribosomal peptide synthetase (NRPS) domain motifs: a condensation-domain signature 'TSGSTGKPKG' (~position 530), adenylation-domain motifs ('YGPTEC', 'GAPVAN'), and a C-terminal thioesterase domain. NRPS enzymes synthesize peptide-type secondary metabolites (pigments such as indigoidine, violacein, prodigiosin; antibiotics; siderophores). Option C (NAD+ biosynthesis, a single-step transferase) and Option D (L-threonine biosynthesis step 2, homoserine dehydrogenase, ~450 aa) are eliminated because a 1488-aa multi-domain NRPS is categorically incompatible with those small single-domain enzymes. Option B (alkaloid biosynthesis) is disfavored because alkaloids are synthesized by entirely different enzymatic machinery (terpene synthases, P450 monooxygenases, methyltransferases), not NRPS assembly lines. Among the remaining choices, NRPS products that are colored compounds (e.g., indigoidine, a dipeptide of L-glutamine) fall squarely under pigment biosynthesis. Thus general NRPS biology plus elimination of incompatible options supports A over B, C, and D.",
    "missing_item_specific_fact": "Precise identification of this NRPS as indigoidine synthase (and thus the specific pigment) requires recognizing the exact sequence or knowing the product of IndC; however, the question can be answered by class-level reasoning without that specific fact.",
    "reason": "The NRPS domain architecture is extractable from sequence motifs, and general knowledge that NRPS products are peptide-type metabolites (not alkaloids, not single-step transferases, not amino-acid biosynthetic enzymes) meaningfully distinguishes A from B, C, and D. The argument does not require memorizing Q9L391's database entry."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "C and D are eliminated by enzyme class and size mismatch. B is disfavored because alkaloid biosynthesis does not employ NRPS assembly lines. A is the only option consistent with a large multi-domain NRPS producing a secondary metabolite among the listed categories. No other option is defensible."
  },
  "important_caveats": [
    "The pathway annotation is experimentally supported (ECO:0000269) but the specific pigment identity (indigoidine) is not derivable from sequence motifs alone; the reasoning argument operates at the NRPS-class level.",
    "The UniProt entry was first publicly released 2025-02-05 (sequence version 2); the author's source snapshot is unknown. The 2002 primary paper predates the Swiss-Prot entry, so the underlying experimental data was available before the benchmark was constructed.",
    "NRPS enzymes also produce antibiotics and siderophores; the question's option set conveniently lacks those alternatives, making 'pigment biosynthesis' the only NRPS-compatible choice. A more challenging distractor set (e.g., 'antibiotic biosynthesis') could have made the question genuinely ambiguous without product-specific knowledge."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches a UniProt record annotated as indigoidine synthase, with the pathway listed as pigment biosynthesis and linked to experimental evidence. Indigoidine is a pigment, so this supports choice A. The cited primary paper is identified in the record but was not independently reviewed here.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The 1488-residue sequence has the scale and motif-rich architecture of a large ATP-dependent nonribosomal-peptide-like synthetase, rather than the kind of enzyme expected for the single-step NAD+ or threonine choices. Transferable knowledge that specialized synthetases of this kind produce complex natural products, including pigment products such as indigoidine, makes pigment biosynthesis a credible choice among these alternatives.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The sequence and broad enzyme-family pattern provide a meaningful probabilistic basis for A over the small-molecule pathway-step options. They do not by themselves establish the exact product, and the distinction from the broad alkaloid category is less direct; nevertheless, family-level knowledge of pigment-producing synthetases makes A a defensible inference rather than requiring the exact protein's database record.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> No alternative is as well supported by the sequence-level family inference and the supplied validation evidence.


### Important caveats

- The pathway annotation is linked to experimental evidence, but the underlying paper was not independently assessed.
- The reviewer-only accession and target-specific annotation are not treated as information available in the original input.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The 1488-residue sequence has the scale and motif-rich architecture of a large ATP-dependent nonribosomal-peptide-like synthetase, rather than the kind of enzyme expected for the single-step NAD+ or threonine choices. Transferable knowledge that specialized synthetases of this kind produce complex natural products, including pigment products such as indigoidine, makes pigment biosynthesis a credible choice among these alternatives.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The sequence and broad enzyme-family pattern provide a meaningful probabilistic basis for A over the small-molecule pathway-step options. They do not by themselves establish the exact product, and the distinction from the broad alkaloid category is less direct; nevertheless, family-level knowledge of pigment-producing synthetases makes A a defensible inference rather than requiring the exact protein's database record."
  },
  "case_id": "pathway_0043",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches a UniProt record annotated as indigoidine synthase, with the pathway listed as pigment biosynthesis and linked to experimental evidence. Indigoidine is a pigment, so this supports choice A. The cited primary paper is identified in the record but was not independently reviewed here."
  },
  "important_caveats": [
    "The pathway annotation is linked to experimental evidence, but the underlying paper was not independently assessed.",
    "The reviewer-only accession and target-specific annotation are not treated as information available in the original input."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "No alternative is as well supported by the sequence-level family inference and the supplied validation evidence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0043",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches a UniProt record annotated as indigoidine synthase, with the pathway listed as pigment biosynthesis and linked to experimental evidence. Indigoidine is a pigment, so this supports choice A. The cited primary paper is identified in the record but was not independently reviewed here.",
    "evidence_ids": ["C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The 1488-residue sequence has the scale and motif-rich architecture of a large ATP-dependent nonribosomal-peptide-like synthetase, rather than the kind of enzyme expected for the single-step NAD+ or threonine choices. Transferable knowledge that specialized synthetases of this kind produce complex natural products, including pigment products such as indigoidine, makes pigment biosynthesis a credible choice among these alternatives.",
    "missing_item_specific_fact": "",
    "reason": "The sequence and broad enzyme-family pattern provide a meaningful probabilistic basis for A over the small-molecule pathway-step options. They do not by themselves establish the exact product, and the distinction from the broad alkaloid category is less direct; nevertheless, family-level knowledge of pigment-producing synthetases makes A a defensible inference rather than requiring the exact protein's database record."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "No alternative is as well supported by the sequence-level family inference and the supplied validation evidence."
  },
  "important_caveats": [
    "The pathway annotation is linked to experimental evidence, but the underlying paper was not independently assessed.",
    "The reviewer-only accession and target-specific annotation are not treated as information available in the original input."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt annotation for Q9L391 (Indigoidine synthase, EC 4.3.3.9) explicitly lists the pathway as 'Pigment biosynthesis' with evidence code ECO:0000269 and PubMed:11790734, which experimentally characterizes indigoidine as a blue pigment and its biosynthetic genes in Erwinia chrysanthemi/Dickeya dadantii. The sequence matches the benchmark sequence (1488 AA, sha256 match confirmed).

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains canonical nonribosomal peptide synthetase (NRPS) domain motifs: the adenylation (A) domain core 'TSGSTGKPKG', condensation (C) domain motif 'GAPVAN', and a phosphopantetheinyl carrier (PCP) region with the conserved serine attachment site. This identifies the protein as an NRPS. Among the four choices: (C) NAD+ from nicotinamide D-ribonucleotide is a simple adenylyltransferase reaction—completely inconsistent with an NRPS; (D) L-threonine from L-aspartate step 2/5 is a dehydrogenase (homoserine dehydrogenase)—also inconsistent with an NRPS. This leaves (A) Pigment biosynthesis and (B) Alkaloid biosynthesis. Transferable knowledge from many bacterial NRPS systems (indigoidine, actinorhodin, violacein, pyoluteorin-related pigments, etc.) establishes NRPS as a hallmark enzymatic platform for bacterial pigment biosynthesis. In contrast, alkaloid biosynthesis pathways predominantly employ decarboxylases, transaminases, P450 monooxygenases, methyltransferases, and terpene cyclases—not NRPS modules. While rare NRPS-derived alkaloids exist (e.g., some fungal ergot alkaloids), the dominant and well-known bacterial NRPS product classes are pigments, antibiotics, siderophores, and toxins. Thus, recognizing NRPS architecture plus the well-established NRPS-pigment association in bacteria meaningfully distinguishes A from B.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A model can identify the NRPS domain architecture from conserved sequence motifs (TSGSTGKPKG, GAPVAN, PCP serine site), then apply the well-established family-level pattern that bacterial NRPS enzymes produce pigments (and antibiotics/siderophores) rather than alkaloids, and are not transferases or dehydrogenases. This eliminates C and D by enzyme-class mismatch and eliminates B by the NRPS-product-class association learned from many other NRPS systems. No fact specific to this exact protein's annotation is strictly required to make the distinction among the four offered choices.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Once the protein is identified as an NRPS, choices C (transferase) and D (dehydrogenase) are clearly incompatible. Between A and B, the strong and well-documented association of bacterial NRPS with pigment biosynthesis versus the general absence of NRPS in alkaloid biosynthesis pathways makes A the clearly superior choice. No reasonable ambiguity remains among the four options.


### Important caveats

- The A-domain specificity-conferring residues (Stachelhaus code) could in principle confirm glutamine activation (consistent with indigoidine), but this level of detail is not necessary to distinguish the offered choices.
- The UniProt annotation uses ECO:0000269 (manual assertion) linked to PubMed:11790734, which provides experimental characterization of indigoidine as a blue pigment and its biosynthetic genes.
- A small number of NRPS enzymes have been annotated under 'Alkaloid biosynthesis' in databases (e.g., some fungal pathways), but these are exceptions and do not undermine the general NRPS-pigment association in bacteria.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains canonical nonribosomal peptide synthetase (NRPS) domain motifs: the adenylation (A) domain core 'TSGSTGKPKG', condensation (C) domain motif 'GAPVAN', and a phosphopantetheinyl carrier (PCP) region with the conserved serine attachment site. This identifies the protein as an NRPS. Among the four choices: (C) NAD+ from nicotinamide D-ribonucleotide is a simple adenylyltransferase reaction—completely inconsistent with an NRPS; (D) L-threonine from L-aspartate step 2/5 is a dehydrogenase (homoserine dehydrogenase)—also inconsistent with an NRPS. This leaves (A) Pigment biosynthesis and (B) Alkaloid biosynthesis. Transferable knowledge from many bacterial NRPS systems (indigoidine, actinorhodin, violacein, pyoluteorin-related pigments, etc.) establishes NRPS as a hallmark enzymatic platform for bacterial pigment biosynthesis. In contrast, alkaloid biosynthesis pathways predominantly employ decarboxylases, transaminases, P450 monooxygenases, methyltransferases, and terpene cyclases—not NRPS modules. While rare NRPS-derived alkaloids exist (e.g., some fungal ergot alkaloids), the dominant and well-known bacterial NRPS product classes are pigments, antibiotics, siderophores, and toxins. Thus, recognizing NRPS architecture plus the well-established NRPS-pigment association in bacteria meaningfully distinguishes A from B.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A model can identify the NRPS domain architecture from conserved sequence motifs (TSGSTGKPKG, GAPVAN, PCP serine site), then apply the well-established family-level pattern that bacterial NRPS enzymes produce pigments (and antibiotics/siderophores) rather than alkaloids, and are not transferases or dehydrogenases. This eliminates C and D by enzyme-class mismatch and eliminates B by the NRPS-product-class association learned from many other NRPS systems. No fact specific to this exact protein's annotation is strictly required to make the distinction among the four offered choices."
  },
  "case_id": "pathway_0043",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt annotation for Q9L391 (Indigoidine synthase, EC 4.3.3.9) explicitly lists the pathway as 'Pigment biosynthesis' with evidence code ECO:0000269 and PubMed:11790734, which experimentally characterizes indigoidine as a blue pigment and its biosynthetic genes in Erwinia chrysanthemi/Dickeya dadantii. The sequence matches the benchmark sequence (1488 AA, sha256 match confirmed)."
  },
  "important_caveats": [
    "The A-domain specificity-conferring residues (Stachelhaus code) could in principle confirm glutamine activation (consistent with indigoidine), but this level of detail is not necessary to distinguish the offered choices.",
    "The UniProt annotation uses ECO:0000269 (manual assertion) linked to PubMed:11790734, which provides experimental characterization of indigoidine as a blue pigment and its biosynthetic genes.",
    "A small number of NRPS enzymes have been annotated under 'Alkaloid biosynthesis' in databases (e.g., some fungal pathways), but these are exceptions and do not undermine the general NRPS-pigment association in bacteria."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Once the protein is identified as an NRPS, choices C (transferase) and D (dehydrogenase) are clearly incompatible. Between A and B, the strong and well-documented association of bacterial NRPS with pigment biosynthesis versus the general absence of NRPS in alkaloid biosynthesis pathways makes A the clearly superior choice. No reasonable ambiguity remains among the four options."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0043",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt annotation for Q9L391 (Indigoidine synthase, EC 4.3.3.9) explicitly lists the pathway as 'Pigment biosynthesis' with evidence code ECO:0000269 and PubMed:11790734, which experimentally characterizes indigoidine as a blue pigment and its biosynthetic genes in Erwinia chrysanthemi/Dickeya dadantii. The sequence matches the benchmark sequence (1488 AA, sha256 match confirmed).",
    "evidence_ids": ["C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains canonical nonribosomal peptide synthetase (NRPS) domain motifs: the adenylation (A) domain core 'TSGSTGKPKG', condensation (C) domain motif 'GAPVAN', and a phosphopantetheinyl carrier (PCP) region with the conserved serine attachment site. This identifies the protein as an NRPS. Among the four choices: (C) NAD+ from nicotinamide D-ribonucleotide is a simple adenylyltransferase reaction—completely inconsistent with an NRPS; (D) L-threonine from L-aspartate step 2/5 is a dehydrogenase (homoserine dehydrogenase)—also inconsistent with an NRPS. This leaves (A) Pigment biosynthesis and (B) Alkaloid biosynthesis. Transferable knowledge from many bacterial NRPS systems (indigoidine, actinorhodin, violacein, pyoluteorin-related pigments, etc.) establishes NRPS as a hallmark enzymatic platform for bacterial pigment biosynthesis. In contrast, alkaloid biosynthesis pathways predominantly employ decarboxylases, transaminases, P450 monooxygenases, methyltransferases, and terpene cyclases—not NRPS modules. While rare NRPS-derived alkaloids exist (e.g., some fungal ergot alkaloids), the dominant and well-known bacterial NRPS product classes are pigments, antibiotics, siderophores, and toxins. Thus, recognizing NRPS architecture plus the well-established NRPS-pigment association in bacteria meaningfully distinguishes A from B.",
    "missing_item_specific_fact": "",
    "reason": "A model can identify the NRPS domain architecture from conserved sequence motifs (TSGSTGKPKG, GAPVAN, PCP serine site), then apply the well-established family-level pattern that bacterial NRPS enzymes produce pigments (and antibiotics/siderophores) rather than alkaloids, and are not transferases or dehydrogenases. This eliminates C and D by enzyme-class mismatch and eliminates B by the NRPS-product-class association learned from many other NRPS systems. No fact specific to this exact protein's annotation is strictly required to make the distinction among the four offered choices."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Once the protein is identified as an NRPS, choices C (transferase) and D (dehydrogenase) are clearly incompatible. Between A and B, the strong and well-documented association of bacterial NRPS with pigment biosynthesis versus the general absence of NRPS in alkaloid biosynthesis pathways makes A the clearly superior choice. No reasonable ambiguity remains among the four options."
  },
  "important_caveats": [
    "The A-domain specificity-conferring residues (Stachelhaus code) could in principle confirm glutamine activation (consistent with indigoidine), but this level of detail is not necessary to distinguish the offered choices.",
    "The UniProt annotation uses ECO:0000269 (manual assertion) linked to PubMed:11790734, which provides experimental characterization of indigoidine as a blue pigment and its biosynthetic genes.",
    "A small number of NRPS enzymes have been annotated under 'Alkaloid biosynthesis' in databases (e.g., some fungal pathways), but these are exceptions and do not undermine the general NRPS-pigment association in bacteria."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "Q9L391",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "3e683829c8442e0bf03ec13937dea8f96def35b5488452f2558692c05563ba91",
  "benchmark_sequence_length": 1488,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 109,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2025-02-05",
    "sequenceVersion": 2
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "9c8d2e104ff5ea8d2790f76bf7752253a7253250c3262d0e137e123b56bf3282",
  "current_source_sequence_sha256": "3e683829c8442e0bf03ec13937dea8f96def35b5488452f2558692c05563ba91",
  "current_source_sequence_length": 1488,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 107,
  "selected_historical_version": {
    "accession": "Q9L391",
    "database": "Swiss-Prot",
    "entryVersion": 107,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "INDGS_DICD3",
    "sequenceVersion": 2
  },
  "selected_historical_record_sha256": "8c41c7f4d955ab759c8a49f6d87170be08a554ecadfde2e1b065f5c3489df877",
  "selected_historical_source_sequence_sha256": "3e683829c8442e0bf03ec13937dea8f96def35b5488452f2558692c05563ba91",
  "selected_historical_source_sequence_length": 1488,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 107,
      "exact_sequence_comparison": "matched",
      "sequence_version": 2
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9L391.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q9L391.json",
  "source_sha256": "9c8d2e104ff5ea8d2790f76bf7752253a7253250c3262d0e137e123b56bf3282",
  "retrieved_utc": "2026-11-02T04:33:04.012566+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"Q9L391\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9L391.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q9L391.json",
  "source_sha256": "9c8d2e104ff5ea8d2790f76bf7752253a7253250c3262d0e137e123b56bf3282",
  "retrieved_utc": "2026-11-02T04:33:04.012566+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":109,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2025-02-05\",\"sequenceVersion\":2}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9L391.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q9L391.json",
  "source_sha256": "9c8d2e104ff5ea8d2790f76bf7752253a7253250c3262d0e137e123b56bf3282",
  "retrieved_utc": "2026-11-02T04:33:04.012566+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"commonName\":\"Erwinia chrysanthemi (strain 3937)\",\"lineage\":[\"Bacteria\",\"Pseudomonadati\",\"Pseudomonadota\",\"Gammaproteobacteria\",\"Enterobacterales\",\"Pectobacteriaceae\",\"Dickeya\"],\"scientificName\":\"Dickeya dadantii (strain 3937)\",\"taxonId\":198628}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9L391.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q9L391.json",
  "source_sha256": "9c8d2e104ff5ea8d2790f76bf7752253a7253250c3262d0e137e123b56bf3282",
  "retrieved_utc": "2026-11-02T04:33:04.012566+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"11790734\",\"source\":\"PubMed\"}],\"value\":\"4.3.3.9\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"value\":\"Indigoidine synthase\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9L391.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q9L391.json",
  "source_sha256": "9c8d2e104ff5ea8d2790f76bf7752253a7253250c3262d0e137e123b56bf3282",
  "retrieved_utc": "2026-11-02T04:33:04.012566+00:00",
  "json_pointer": "/comments/5",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"11790734\",\"source\":\"PubMed\"}],\"value\":\"Pigment biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9L391.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q9L391.json",
  "source_sha256": "9c8d2e104ff5ea8d2790f76bf7752253a7253250c3262d0e137e123b56bf3282",
  "retrieved_utc": "2026-11-02T04:33:04.012566+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Reverchon S.\",\"Rouanet C.\",\"Expert D.\",\"Nasser W.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"11790734\"},{\"database\":\"DOI\",\"id\":\"10.1128/jb.184.3.654-665.2002\"}],\"citationType\":\"journal article\",\"firstPage\":\"654\",\"id\":\"11790734\",\"journal\":\"J. Bacteriol.\",\"lastPage\":\"665\",\"publicationDate\":\"2002\",\"title\":\"Characterization of indigoidine biosynthetic genes in Erwinia chrysanthemi and role of this blue pigment in pathogenicity.\",\"volume\":\"184\"},\"evidences\":[{\"evidenceCode\":\"ECO:0000312\",\"id\":\"CAB87990.1\",\"source\":\"EMBL\"}],\"referenceComments\":[{\"type\":\"STRAIN\",\"value\":\"3937\"}],\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"FUNCTION AS AN INDIGOIDINE SYNTHASE\",\"PATHWAY\",\"INDUCTION\",\"DOMAIN\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q9L391?format=txt&versions=107)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/Q9L391?format=txt&versions=107",
  "source_sha256": "8c41c7f4d955ab759c8a49f6d87170be08a554ecadfde2e1b065f5c3489df877",
  "retrieved_utc": "2026-11-02T04:33:06.750542+00:00",
  "source_locator": "lines 1-13",
  "excerpt": "ID   INDGS_DICD3             Reviewed;        1488 AA.\nAC   Q9L391; E0SMH6;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   05-FEB-2025, sequence version 2.\nDT   28-JAN-2026, entry version 107.\nDE   RecName: Full=Indigoidine synthase {ECO:0000305};\nDE            EC=4.3.3.9 {ECO:0000305|PubMed:11790734};\nGN   Name=indC {ECO:0000303|PubMed:11790734};\nGN   OrderedLocusNames=Dda3937_00972 {ECO:0000312|EMBL:ADN00615.1};\nOS   Dickeya dadantii (strain 3937) (Erwinia chrysanthemi (strain 3937)).\nOC   Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria;\nOC   Enterobacterales; Pectobacteriaceae; Dickeya.\nOX   NCBI_TaxID=198628;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 107,
  "sequence_version": 2,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q9L391?format=txt&versions=107)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/Q9L391?format=txt&versions=107",
  "source_sha256": "8c41c7f4d955ab759c8a49f6d87170be08a554ecadfde2e1b065f5c3489df877",
  "retrieved_utc": "2026-11-02T04:33:06.750542+00:00",
  "source_locator": "lines 14-22",
  "excerpt": "RN   [1] {ECO:0000312|EMBL:CAB87990.1}\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION AS AN INDIGOIDINE SYNTHASE,\nRP   PATHWAY, INDUCTION, AND DOMAIN.\nRC   STRAIN=3937;\nRX   PubMed=11790734; DOI=10.1128/jb.184.3.654-665.2002;\nRA   Reverchon S., Rouanet C., Expert D., Nasser W.;\nRT   \"Characterization of indigoidine biosynthetic genes in Erwinia chrysanthemi\nRT   and role of this blue pigment in pathogenicity.\";\nRL   J. Bacteriol. 184:654-665(2002).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 107,
  "sequence_version": 2,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q9L391?format=txt&versions=107)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/Q9L391?format=txt&versions=107",
  "source_sha256": "8c41c7f4d955ab759c8a49f6d87170be08a554ecadfde2e1b065f5c3489df877",
  "retrieved_utc": "2026-11-02T04:33:06.750542+00:00",
  "source_locator": "lines 71-71",
  "excerpt": "CC   -!- PATHWAY: Pigment biosynthesis. {ECO:0000269|PubMed:11790734}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 107,
  "sequence_version": 2,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 43. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
